Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Assessment of Immediate Pre-Sleep Caffeine Administration on Self-Reported Post-Nap Irritability and Cognitive Fog in Overworked Adults

NCT07635303 is registered in ClinicalTrials.gov with Hightower Clinical as lead sponsor.

NCT NCT07635303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07635303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Assessment of Immediate Pre-Sleep Caffeine Administration on Self-Reported Post-Nap Irritability and Cognitive Fog in Overworked Adults
Lead sponsor
Hightower Clinical
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
July 1, 2028
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

irritability